Platinum-Resistant Lung Small Cell Carcinoma
specificLung small cell carcinoma that is resistant to platinum therapy.
11
Centers
13
Active Trials
—
Cancer Funding
Top Centers for Platinum-Resistant Lung Small Cell Carcinoma(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive High-Volume Research Center | 73.0 |
| 2 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive High-Volume Research Center | 73.0 |
| 3 | NCI Comprehensive Active Research Program | 50.5 |
| 4 | NCI Comprehensive Active Research Program | 50.5 |
| 5 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 50.5 |
| 6 | NCI Comprehensive Active Research Program | 50.5 |
| 7 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 50.5 |
| 8 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 50.5 |
| 9 | University of Illinois Cancer CenterChicago, IL Active Research Program | 50.5 |
| 10 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 50.5 |
| 11 | Cancer Center at IllinoisUrbana, IL Active Research Program | 50.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →